CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 268 enrolled
Drug / intervention
Simethicone Solution +1 moredrug
Likely dose
Not stated in record
Key inclusion· 4
  • ✓Age 30-80 years
  • ✓Scheduled for screening colonoscopy
  • ✓Ambulatory status
  • ✓Male and female patients
Key exclusion· 6
  • ✕Prior colonic surgery
  • ✕Mental or physical condition impairing oral ingestion of bowel preparation
  • ✕Allergy or hypersensitivity to simethicone
  • ✕Limited mobility (bedridden)

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03119168
NCT03119168Phase 4Completed
CompareCT.gov

The Effect Of Adding High Dose Simethicone To A Standard Polyethylene Glycol Preparation On Adenoma Detection Rate During Screening Colonoscopy: A Randomized Controlled Pilot Trial

Texas Tech University Health Sciences Center, El Paso·interventional·Posted Apr 18, 2017·Updated Jun 5, 2019

In Brief

A Phase 4 clinical trial evaluating Simethicone Solution and Polyethylenglycol for Adenoma Colon. Completed, enrolled 268 participants across 1 site.

Detailed Summary

This study is evaluating the effect of adding a high dose of simethicone to the standard polyethylene glycol preparation for screening colonoscopy in the quality of the preparation , adenoma detection rate and withdrawal times.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdenoma Colon
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedApr 18, 2017
Enrollment StartMar 15, 2017
Primary CompletionApr 10, 2019
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 9.2 years ago

Interventions

Simethicone Solutiondrug

Patients will be assigned randomly to take Simethicone Solution plus polyethylenglycol

Polyethylenglycolother

Patients in this arm will be randomly assigned to take polyethylenglycol as their regular bowel preparation